Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1988 May 1;251(3):757–762. doi: 10.1042/bj2510757

A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase.

J D Rothermel 1, L H Parker Botelho 1
PMCID: PMC1149068  PMID: 2843164

Abstract

The binding affinities of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate, Sp-cAMP[S] and Rp-cAMP[S], for the cyclic AMP- (cAMP-)binding sites on purified and reconstituted pig heart type II cAMP-dependent protein kinase holoenzyme were determined by measuring the ability of these compounds to displace [3H]cAMP from this enzyme. Sp-cAMP[S], a cAMP agonist, displaced 50% of the [3H]cAMP bound to the holoenzyme at a concentration 10-fold higher than that of cAMP; Rp-cAMP[S], a cAMP antagonist, required a 100-fold higher concentration relative to cAMP. Activation of the isolated holoenzyme, determined as phosphotransferase activity, was measured in the presence of the agonist and in the absence and in the presence of increasing concentrations of the antagonist. The results of fitting the activation data to sigmoid curves with a non-linear-regression program and to Hill plots by using a linear-regression program showed that Rp-cAMP[S] had no effect on Vmax, increased the EC50 values for agonist activation and had no effect on the co-operativity of activation (h). A Ki value of 11 microM was determined for Rp-cAMP[S] inhibition of cAMP-induced activation of purified type II cAMP-dependent protein kinase. Electrophoresis of the holoenzyme on polyacrylamide gels under non-denaturing conditions in the presence of saturating concentrations of the diastereoisomers resulted in 100% dissociation of the subunits with Sp-cAMP[S] and 0% dissociation with Rp-cAMP[S]. Sp-cAMP[S], the isomer with an axial exocyclic sulphur atom, binds to the holoenzyme, releases the catalytic subunit and activates the phosphotransferase activity. Rp-cAMP[S], the isomer with an equatorial exocyclic sulphur atom, binds to the holoenzyme but does not result in dissociation, and thus acts as a competitive inhibitor of phosphotransferase activity.

Full text

PDF
757

Images in this article

761Fig. 3.
on p.761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beavo J. A., Bechtel P. J., Krebs E. G. Activation of protein kinase by physiological concentrations of cyclic AMP. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3580–3583. doi: 10.1073/pnas.71.9.3580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beavo J. A., Bechtel P. J., Krebs E. G. Mechanisms of control for cAMP-dependent protein kinase from skeletal muscle. Adv Cyclic Nucleotide Res. 1975;5:241–251. [PubMed] [Google Scholar]
  3. Cherrington A. D., Assimacopoulos F. D., Harper S. C., Corbin J. D., Park C. R., Exton J. H. Studies on the alpha-andrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in the actions of phenylephrine in isolated hepatocytes. J Biol Chem. 1976 Sep 10;251(17):5209–5218. [PubMed] [Google Scholar]
  4. Corbin J. D., Sugden P. H., West L., Flockhart D. A., Lincoln T. M., McCarthy D. Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem. 1978 Jun 10;253(11):3997–4003. [PubMed] [Google Scholar]
  5. Doskeland S. O., Ueland P. M., Haga H. J. Factors affecting the binding of [3H]adenosine 3':5'-cyclic monophosphate to protein kinase from bovine adrenal cortex. Biochem J. 1977 Mar 1;161(3):653–665. doi: 10.1042/bj1610653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dragland-Meserve C. J., Olivieri M. C., Botelho L. H. Inhibition of hepatic gluconeogenesis by the Rp-diastereomer of adenosine cyclic 3',5'-phosphorothioate. Biochem J. 1986 Jul 15;237(2):463–468. doi: 10.1042/bj2370463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Døskeland S. O., Haga H. J. Measurement of adenosine 3':5'-cyclic monophosphate by competitive binding to salt-dissociated protein kinase. Biochem J. 1978 Aug 15;174(2):363–372. doi: 10.1042/bj1740363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kerlavage A. R., Taylor S. S. Site-specific cyclic nucleotide binding and dissociation of the holoenzyme of cAMP-dependent protein kinase. J Biol Chem. 1982 Feb 25;257(4):1749–1754. [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Marks J. S., Botelho L. H. Synergistic inhibition of hepatic glycogenolysis in the presence of insulin and a cAMP antagonist. J Biol Chem. 1986 Feb 25;261(6):2781–2785. [PubMed] [Google Scholar]
  11. Ogreid D., Døskeland S. O. Activation of protein kinase isoenzymes under near physiological conditions. Evidence that both types (A and B) of cAMP binding sites are involved in the activation of protein kinase by cAMP and 8-N3-cAMP. FEBS Lett. 1982 Dec 13;150(1):161–166. doi: 10.1016/0014-5793(82)81326-4. [DOI] [PubMed] [Google Scholar]
  12. Ogreid D., Døskeland S. O. Protein kinase II has two distinct binding sites for cyclic AMP, only one of which is detectable by the conventional membrane-filtration method. FEBS Lett. 1980 Dec 1;121(2):340–344. doi: 10.1016/0014-5793(80)80376-0. [DOI] [PubMed] [Google Scholar]
  13. Rothermel J. D., Jastorff B., Botelho L. H. Inhibition of glucagon-induced glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate. J Biol Chem. 1984 Jul 10;259(13):8151–8155. [PubMed] [Google Scholar]
  14. Rothermel J. D., Perillo N. L., Marks J. S., Botelho L. H. Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic 3',5'-phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase. J Biol Chem. 1984 Dec 25;259(24):15294–15300. [PubMed] [Google Scholar]
  15. Rothermel J. D., Stec W. J., Baraniak J., Jastorff B., Botelho L. H. Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate. J Biol Chem. 1983 Oct 25;258(20):12125–12128. [PubMed] [Google Scholar]
  16. Schwechheimer K., Hofmann F. Properties of regulatory subunit of cyclic AMP-dependent protein kinase (peak I) from rabbit skeletal muscle prepared by urea treatment of the holoenzyme. J Biol Chem. 1977 Nov 10;252(21):7690–7696. [PubMed] [Google Scholar]
  17. Swillens S. On the interactions of adenosine 3',5'-monophosphate with the components of protein kinase I. A theoretical equilibrium analysis. Eur J Biochem. 1983 Dec 15;137(3):581–587. doi: 10.1111/j.1432-1033.1983.tb07865.x. [DOI] [PubMed] [Google Scholar]
  18. Weber W., Hilz H. Stoichiometry of cAMP binding and limited proteolysis of protein kinase regulatory subunits R I and R II. Biochem Biophys Res Commun. 1979 Oct 12;90(3):1074–1081. doi: 10.1016/0006-291x(79)91935-1. [DOI] [PubMed] [Google Scholar]
  19. Witt J. J., Roskoski R., Jr Adenosine 3',5'-monophosphate-dependent protein kinase: interaction with guanidinium compounds. Arch Biochem Biophys. 1980 Apr 15;201(1):36–43. doi: 10.1016/0003-9861(80)90484-1. [DOI] [PubMed] [Google Scholar]
  20. de Wit R. J., Hekstra D., Jastorff B., Stec W. J., Baraniak J., Van Driel R., Van Haastert P. J. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases. Eur J Biochem. 1984 Jul 16;142(2):255–260. doi: 10.1111/j.1432-1033.1984.tb08279.x. [DOI] [PubMed] [Google Scholar]
  21. de Wit R. J., Hoppe J., Stec W. J., Baraniak J., Jastorff B. Interaction of cAMP derivatives with the 'stable' cAMP-binding site in the cAMP-dependent protein kinase type I. Eur J Biochem. 1982 Feb;122(1):95–99. doi: 10.1111/j.1432-1033.1982.tb05852.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES